Haemosol

Haemosol is a range of dialysis solutions developed and marketed by Duopharma Biotech, primarily used in the management of renal disease and End-Stage Renal Disease (ESRD). These solutions are designed for use in hemodialysis and continuous renal replacement therapy (CRRT) to facilitate the removal of metabolic waste products, correct electrolyte imbalances, and maintain acid-base homeostasis in patients with impaired kidney function. The product line includes bicarbonate-buffered formulations, such as Bi-haemosol, which are essential for providing physiological pH correction during dialysis procedures. By acting as a dialysate, Haemosol enables the diffusion and convection of uremic toxins across a semi-permeable membrane, effectively substituting for the filtration function of the kidneys.

Brand names

HaemosolBi-haemosol

Other names

Bi-haemosolHaemosol B0